Peter D. Gorycki
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Hepatology top 10%
- Liver physiology and pathology
Papers in
- Oncology 12
- Drug Transport and Resistance Mechanisms 5
- Chemokine receptors and signaling 2
-
- Pharmacogenetics and Drug Metabolism 3
- Drug-Induced Hepatotoxicity and Protection 3
- Co-authors
- Edward F. Webb (3 shared papers)Don E. Griswold (3 shared papers)Theodore J. Torphy (3 shared papers)Yanli Deng (5 shared papers)Jan Georg Hengstler (1 shared paper)Roger Rahmani (1 shared paper)Albert P. Li (1 shared paper)Gregory L. Kedderis (1 shared paper)
- Journals
- Drug Metabolism and Disposition (5 papers)Xenobiotica (4 papers)Chemical Research in Toxicology (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Peter D. Gorycki
28 papers receiving 741 citations
Peers
Comparison fields: 5 of 88
- Pharmacology 127
- Hepatology 62
- Oncology 165
- Organic Chemistry 158
- Molecular Biology 367
Countries citing papers authored by Peter D. Gorycki
This map shows the geographic impact of Peter D. Gorycki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Gorycki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Gorycki more than expected).
Fields of papers citing papers by Peter D. Gorycki
This network shows the impact of papers produced by Peter D. Gorycki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Gorycki. The network helps show where Peter D. Gorycki may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter D. Gorycki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 124 | |
| 2 | 1998 | 102 | |
| 3 | SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo. | 1998 | 81 |
| 4 | 2012 | 78 | |
| 5 | 1998 | 64 | |
| 6 | 2011 | 43 | |
| 7 | 2013 | 40 | |
| 8 | 1998 | 36 | |
| 9 | 2004 | 35 | |
| 10 | 2006 | 33 | |
| 11 | 1989 | 28 | |
| 12 | 2019 | 17 | |
| 13 | 1985 | 13 | |
| 14 | 1989 | 11 | |
| 15 | 2022 | 11 | |
| 16 | 2011 | 11 | |
| 17 | 2002 | 11 | |
| 18 | 2011 | 10 | |
| 19 | 2014 | 9 | |
| 20 | 1990 | 9 |
About Peter D. Gorycki
Peter D. Gorycki is a scholar working on Oncology, Pharmacology, Molecular Biology, Hematology and Organic Chemistry, having authored 29 papers that have together received 804 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Melanoma and MAPK Pathways (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Neuropeptides and Animal Physiology (3 papers), Phosphodiesterase function and regulation (3 papers), Gastrointestinal motility and disorders (2 papers) and Chemokine receptors and signaling (2 papers). The work is most often cited by research in Pharmacology (127 citations), Hepatology (62 citations), Oncology (165 citations), Organic Chemistry (158 citations) and Molecular Biology (367 citations). Peter D. Gorycki has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Edward F. Webb, Don E. Griswold, Theodore J. Torphy, Yanli Deng, Jan Georg Hengstler, Roger Rahmani, Albert P. Li, Gregory L. Kedderis, Paul Skett and José M. Silva. Their work appears in journals such as Drug Metabolism and Disposition, Xenobiotica, Chemical Research in Toxicology, Bioorganic & Medicinal Chemistry Letters and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.